- Home
- HKPD vs JUNS Comparison
HKPD vs JUNS Comparison
Compare HKPD & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKPD
- JUNS
- Stock Information
- Founded
- HKPD 2016
- JUNS 2015
- Country
- HKPD Hong Kong
- JUNS United States
- Employees
- HKPD N/A
- JUNS N/A
- Industry
- HKPD Other Pharmaceuticals
- JUNS
- Sector
- HKPD Health Care
- JUNS
- Exchange
- HKPD Nasdaq
- JUNS NYSE
- Market Cap
- HKPD 20.9M
- JUNS 20.5M
- IPO Year
- HKPD 2025
- JUNS 2024
- Fundamental
- Price
- HKPD $1.54
- JUNS $1.11
- Analyst Decision
- HKPD
- JUNS
- Analyst Count
- HKPD 0
- JUNS 0
- Target Price
- HKPD N/A
- JUNS N/A
- AVG Volume (30 Days)
- HKPD 3.3M
- JUNS 723.0K
- Earning Date
- HKPD 01-01-0001
- JUNS 08-11-2025
- Dividend Yield
- HKPD N/A
- JUNS N/A
- EPS Growth
- HKPD N/A
- JUNS N/A
- EPS
- HKPD 0.21
- JUNS N/A
- Revenue
- HKPD $20,770,344.00
- JUNS N/A
- Revenue This Year
- HKPD N/A
- JUNS N/A
- Revenue Next Year
- HKPD N/A
- JUNS N/A
- P/E Ratio
- HKPD $7.21
- JUNS N/A
- Revenue Growth
- HKPD 32.91
- JUNS N/A
- 52 Week Low
- HKPD $0.81
- JUNS $0.51
- 52 Week High
- HKPD $3.79
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- HKPD N/A
- JUNS N/A
- Support Level
- HKPD N/A
- JUNS N/A
- Resistance Level
- HKPD N/A
- JUNS N/A
- Average True Range (ATR)
- HKPD 0.00
- JUNS 0.00
- MACD
- HKPD 0.00
- JUNS 0.00
- Stochastic Oscillator
- HKPD 0.00
- JUNS 0.00
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.